| Primary |
| Attention Deficit/hyperactivity Disorder |
52.6% |
| Product Used For Unknown Indication |
18.9% |
| Ill-defined Disorder |
5.0% |
| Depression |
3.9% |
| Suicide Attempt |
3.9% |
| Oppositional Defiant Disorder |
1.9% |
| Adhd |
1.4% |
| Psychomotor Hyperactivity |
1.4% |
| Disturbance In Attention |
1.1% |
| Fibromyalgia |
1.1% |
| Sleep Disorder |
1.1% |
| Somnolence |
1.1% |
| Aggression |
0.8% |
| Apathy |
0.8% |
| Cognitive Disorder |
0.8% |
| Mood Altered |
0.8% |
| Off Label Use |
0.8% |
| Parkinson's Disease |
0.8% |
| Psychotic Disorder |
0.8% |
| Acquired Epileptic Aphasia |
0.6% |
|
| Product Substitution Issue |
20.1% |
| Completed Suicide |
9.5% |
| Toxicity To Various Agents |
7.7% |
| Sudden Death |
6.5% |
| Death |
5.9% |
| Drug Ineffective |
5.3% |
| Tachycardia |
4.7% |
| Suicide Attempt |
4.1% |
| Therapeutic Response Unexpected With Drug Substitution |
4.1% |
| Drug Abuse |
3.6% |
| Irritability |
3.6% |
| Ventricular Parasystole |
3.6% |
| Dyskinesia |
3.0% |
| Psychotic Disorder |
3.0% |
| Tic |
3.0% |
| Weight Decreased |
3.0% |
| Abnormal Behaviour |
2.4% |
| Decreased Appetite |
2.4% |
| Raynaud's Phenomenon |
2.4% |
| Somnolence |
2.4% |
|
| Secondary |
| Product Used For Unknown Indication |
44.3% |
| Attention Deficit/hyperactivity Disorder |
18.8% |
| Drug Use For Unknown Indication |
13.2% |
| Aggression |
2.5% |
| Depression |
2.4% |
| Abnormal Behaviour |
2.3% |
| Psychomotor Hyperactivity |
2.3% |
| Ill-defined Disorder |
1.9% |
| Autism |
1.8% |
| Narcolepsy |
1.6% |
| Post-traumatic Stress Disorder |
1.5% |
| Migraine |
1.2% |
| Psychotic Disorder |
1.1% |
| Psychomotor Retardation |
1.0% |
| Myoclonus |
0.8% |
| Poisoning Deliberate |
0.8% |
| Generalised Anxiety Disorder |
0.7% |
| Affect Lability |
0.7% |
| Bipolar Disorder |
0.7% |
| Obsessive-compulsive Disorder |
0.7% |
|
| Completed Suicide |
19.6% |
| Toxicity To Various Agents |
11.6% |
| Tachycardia |
9.0% |
| Respiratory Arrest |
6.5% |
| Multiple Drug Overdose |
5.5% |
| Death |
5.0% |
| Suicide Attempt |
5.0% |
| Withdrawal Syndrome |
5.0% |
| Poisoning |
4.0% |
| Cardiac Arrest |
3.5% |
| Cardio-respiratory Arrest |
3.0% |
| Growth Retardation |
3.0% |
| Myalgia |
3.0% |
| Weight Decreased |
3.0% |
| Dyskinesia |
2.5% |
| Thrombocytopenia |
2.5% |
| Decreased Appetite |
2.0% |
| Drug Ineffective |
2.0% |
| Drug Interaction |
2.0% |
| Overdose |
2.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
27.6% |
| Attention Deficit/hyperactivity Disorder |
13.4% |
| Pain |
9.3% |
| Depression |
7.8% |
| Multiple Sclerosis |
7.8% |
| Drug Use For Unknown Indication |
3.1% |
| Narcolepsy |
2.9% |
| Hypertension |
2.8% |
| Anxiety |
2.7% |
| Fatigue |
2.5% |
| Headache |
2.5% |
| Cataplexy |
2.4% |
| Migraine |
2.3% |
| Nausea |
2.2% |
| Insomnia |
1.9% |
| Sleep Disorder |
1.9% |
| Oral Infection |
1.8% |
| Gastrooesophageal Reflux Disease |
1.6% |
| Ovarian Cancer |
1.6% |
| Rheumatoid Arthritis |
1.5% |
|
| Vomiting |
11.7% |
| Weight Decreased |
10.2% |
| Weight Increased |
8.3% |
| Completed Suicide |
5.4% |
| Progressive Multifocal Leukoencephalopathy |
5.4% |
| Urinary Tract Infection |
5.4% |
| Convulsion |
4.9% |
| Suicide Attempt |
4.9% |
| Toxicity To Various Agents |
4.9% |
| Rash |
4.4% |
| Somnambulism |
4.4% |
| Drug Ineffective |
3.9% |
| Off Label Use |
3.9% |
| White Blood Cell Count Decreased |
3.9% |
| Death |
3.4% |
| Suicidal Ideation |
3.4% |
| Cellulitis |
2.9% |
| Dizziness |
2.9% |
| Fatigue |
2.9% |
| Myocardial Infarction |
2.9% |
|
| Interacting |
| Attention Deficit/hyperactivity Disorder |
24.2% |
| Product Used For Unknown Indication |
24.2% |
| Depression |
15.2% |
| Alcoholism |
9.1% |
| Ill-defined Disorder |
6.1% |
| Psychomotor Retardation |
6.1% |
| Small For Dates Baby |
6.1% |
| Hypervigilance |
3.0% |
| Mania |
3.0% |
| Sleep Disorder |
3.0% |
|
| Drug Interaction |
35.7% |
| Psychotic Disorder |
21.4% |
| Akathisia |
7.1% |
| Limb Discomfort |
7.1% |
| Restlessness |
7.1% |
| Serotonin Syndrome |
7.1% |
| Swelling |
7.1% |
| White Blood Cell Count Increased |
7.1% |
|
